PRINCETON, N.J. (AP) _ Agile Therapeutics Inc. (AGRX) on Wednesday reported a loss of $5.2 million in its fourth quarter.
On a per-share basis, the Princeton, New Jersey-based company said it had a loss of 18 cents. Losses, adjusted for pretax gains, were 29 cents per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.
For the year, the company reported a loss of $28.7 million, or $1.02 per share.
In the final minutes of trading on Wednesday, the company's shares hit $2.15. A year ago, they were trading at $5.97.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGRX at https://www.zacks.com/ap/AGRX
Keywords: Agile Therapeutics, Earnings Report